nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—Methylprednisolone—psoriatic arthritis	0.176	0.279	CbGbCtD
Nadolol—ABCB1—Betamethasone—psoriatic arthritis	0.114	0.182	CbGbCtD
Nadolol—ABCB1—Prednisolone—psoriatic arthritis	0.113	0.179	CbGbCtD
Nadolol—ABCB1—Prednisone—psoriatic arthritis	0.106	0.169	CbGbCtD
Nadolol—ABCB1—Dexamethasone—psoriatic arthritis	0.0664	0.106	CbGbCtD
Nadolol—ABCB1—Methotrexate—psoriatic arthritis	0.0534	0.0849	CbGbCtD
Nadolol—Pulmonary oedema—Triamcinolone—psoriatic arthritis	0.00207	0.00558	CcSEcCtD
Nadolol—Pulmonary oedema—Methylprednisolone—psoriatic arthritis	0.00207	0.00556	CcSEcCtD
Nadolol—Cardiac failure congestive—Prednisolone—psoriatic arthritis	0.00202	0.00545	CcSEcCtD
Nadolol—Fluid retention—Dexamethasone—psoriatic arthritis	0.002	0.0054	CcSEcCtD
Nadolol—Fluid retention—Betamethasone—psoriatic arthritis	0.002	0.0054	CcSEcCtD
Nadolol—Pruritus—Auranofin—psoriatic arthritis	0.002	0.00539	CcSEcCtD
Nadolol—Dry eye—Betamethasone—psoriatic arthritis	0.00195	0.00525	CcSEcCtD
Nadolol—Dry eye—Dexamethasone—psoriatic arthritis	0.00195	0.00525	CcSEcCtD
Nadolol—Visual disturbance—Prednisolone—psoriatic arthritis	0.00194	0.00522	CcSEcCtD
Nadolol—Diarrhoea—Auranofin—psoriatic arthritis	0.00194	0.00522	CcSEcCtD
Nadolol—Pulmonary oedema—Betamethasone—psoriatic arthritis	0.00188	0.00506	CcSEcCtD
Nadolol—Pulmonary oedema—Dexamethasone—psoriatic arthritis	0.00188	0.00506	CcSEcCtD
Nadolol—Cardiac failure congestive—Triamcinolone—psoriatic arthritis	0.00186	0.00501	CcSEcCtD
Nadolol—Cardiac failure congestive—Methylprednisolone—psoriatic arthritis	0.00186	0.005	CcSEcCtD
Nadolol—Affect lability—Prednisolone—psoriatic arthritis	0.00181	0.00487	CcSEcCtD
Nadolol—Vomiting—Auranofin—psoriatic arthritis	0.0018	0.00485	CcSEcCtD
Nadolol—Amnesia—Methylprednisolone—psoriatic arthritis	0.00179	0.00483	CcSEcCtD
Nadolol—Rash—Auranofin—psoriatic arthritis	0.00178	0.00481	CcSEcCtD
Nadolol—Dermatitis—Auranofin—psoriatic arthritis	0.00178	0.0048	CcSEcCtD
Nadolol—Fluid retention—Prednisone—psoriatic arthritis	0.00174	0.0047	CcSEcCtD
Nadolol—Mood swings—Prednisolone—psoriatic arthritis	0.00174	0.00468	CcSEcCtD
Nadolol—Cardiac failure—Methylprednisolone—psoriatic arthritis	0.00173	0.00465	CcSEcCtD
Nadolol—Cardiac failure congestive—Dexamethasone—psoriatic arthritis	0.00169	0.00455	CcSEcCtD
Nadolol—Cardiac failure congestive—Betamethasone—psoriatic arthritis	0.00169	0.00455	CcSEcCtD
Nadolol—Dry skin—Prednisolone—psoriatic arthritis	0.00168	0.00453	CcSEcCtD
Nadolol—Nausea—Auranofin—psoriatic arthritis	0.00168	0.00453	CcSEcCtD
Nadolol—Affect lability—Triamcinolone—psoriatic arthritis	0.00166	0.00448	CcSEcCtD
Nadolol—Affect lability—Methylprednisolone—psoriatic arthritis	0.00166	0.00447	CcSEcCtD
Nadolol—Pulmonary oedema—Prednisone—psoriatic arthritis	0.00164	0.00441	CcSEcCtD
Nadolol—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.00162	0.00437	CcSEcCtD
Nadolol—Dysarthria—Methotrexate—psoriatic arthritis	0.00162	0.00437	CcSEcCtD
Nadolol—Visual disturbance—Betamethasone—psoriatic arthritis	0.00162	0.00435	CcSEcCtD
Nadolol—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00162	0.00435	CcSEcCtD
Nadolol—Irritability—Methylprednisolone—psoriatic arthritis	0.00161	0.00433	CcSEcCtD
Nadolol—Mood swings—Triamcinolone—psoriatic arthritis	0.0016	0.00431	CcSEcCtD
Nadolol—Abdominal distension—Prednisolone—psoriatic arthritis	0.0016	0.0043	CcSEcCtD
Nadolol—Mood swings—Methylprednisolone—psoriatic arthritis	0.0016	0.0043	CcSEcCtD
Nadolol—Cardiac failure—Dexamethasone—psoriatic arthritis	0.00157	0.00423	CcSEcCtD
Nadolol—Cardiac failure—Betamethasone—psoriatic arthritis	0.00157	0.00423	CcSEcCtD
Nadolol—Lethargy—Betamethasone—psoriatic arthritis	0.00156	0.00421	CcSEcCtD
Nadolol—Lethargy—Dexamethasone—psoriatic arthritis	0.00156	0.00421	CcSEcCtD
Nadolol—Affect lability—Dexamethasone—psoriatic arthritis	0.00151	0.00406	CcSEcCtD
Nadolol—Affect lability—Betamethasone—psoriatic arthritis	0.00151	0.00406	CcSEcCtD
Nadolol—Cardiac failure congestive—Prednisone—psoriatic arthritis	0.00147	0.00396	CcSEcCtD
Nadolol—Abdominal distension—Triamcinolone—psoriatic arthritis	0.00147	0.00396	CcSEcCtD
Nadolol—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00147	0.00395	CcSEcCtD
Nadolol—Irritability—Betamethasone—psoriatic arthritis	0.00146	0.00394	CcSEcCtD
Nadolol—Irritability—Dexamethasone—psoriatic arthritis	0.00146	0.00394	CcSEcCtD
Nadolol—Mood swings—Dexamethasone—psoriatic arthritis	0.00145	0.00391	CcSEcCtD
Nadolol—Mood swings—Betamethasone—psoriatic arthritis	0.00145	0.00391	CcSEcCtD
Nadolol—Weight increased—Prednisolone—psoriatic arthritis	0.00144	0.00389	CcSEcCtD
Nadolol—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00143	0.00386	CcSEcCtD
Nadolol—Amnesia—Prednisone—psoriatic arthritis	0.00142	0.00382	CcSEcCtD
Nadolol—Dry skin—Dexamethasone—psoriatic arthritis	0.0014	0.00378	CcSEcCtD
Nadolol—Dry skin—Betamethasone—psoriatic arthritis	0.0014	0.00378	CcSEcCtD
Nadolol—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00137	0.0037	CcSEcCtD
Nadolol—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.00137	0.00368	CcSEcCtD
Nadolol—Cardiac failure—Prednisone—psoriatic arthritis	0.00137	0.00368	CcSEcCtD
Nadolol—Lethargy—Prednisone—psoriatic arthritis	0.00136	0.00367	CcSEcCtD
Nadolol—Weight increased—Triamcinolone—psoriatic arthritis	0.00133	0.00358	CcSEcCtD
Nadolol—Weight increased—Methylprednisolone—psoriatic arthritis	0.00132	0.00357	CcSEcCtD
Nadolol—Affect lability—Prednisone—psoriatic arthritis	0.00131	0.00354	CcSEcCtD
Nadolol—Bradycardia—Prednisolone—psoriatic arthritis	0.00129	0.00348	CcSEcCtD
Nadolol—Irritability—Prednisone—psoriatic arthritis	0.00127	0.00343	CcSEcCtD
Nadolol—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00126	0.00341	CcSEcCtD
Nadolol—Mood swings—Prednisone—psoriatic arthritis	0.00126	0.0034	CcSEcCtD
Nadolol—Sweating—Methylprednisolone—psoriatic arthritis	0.00124	0.00335	CcSEcCtD
Nadolol—Visual impairment—Prednisolone—psoriatic arthritis	0.00122	0.0033	CcSEcCtD
Nadolol—Dry skin—Prednisone—psoriatic arthritis	0.00122	0.00329	CcSEcCtD
Nadolol—Weight increased—Betamethasone—psoriatic arthritis	0.0012	0.00325	CcSEcCtD
Nadolol—Weight increased—Dexamethasone—psoriatic arthritis	0.0012	0.00325	CcSEcCtD
Nadolol—Bradycardia—Triamcinolone—psoriatic arthritis	0.00119	0.0032	CcSEcCtD
Nadolol—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00119	0.0032	CcSEcCtD
Nadolol—Visual disturbance—Methotrexate—psoriatic arthritis	0.00118	0.00317	CcSEcCtD
Nadolol—Abdominal distension—Prednisone—psoriatic arthritis	0.00116	0.00313	CcSEcCtD
Nadolol—Hallucination—Methylprednisolone—psoriatic arthritis	0.00116	0.00312	CcSEcCtD
Nadolol—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00115	0.00309	CcSEcCtD
Nadolol—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00115	0.00309	CcSEcCtD
Nadolol—Lethargy—Methotrexate—psoriatic arthritis	0.00114	0.00306	CcSEcCtD
Nadolol—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00112	0.00303	CcSEcCtD
Nadolol—Bradycardia—Dexamethasone—psoriatic arthritis	0.00108	0.00291	CcSEcCtD
Nadolol—Bradycardia—Betamethasone—psoriatic arthritis	0.00108	0.00291	CcSEcCtD
Nadolol—Irritability—Methotrexate—psoriatic arthritis	0.00106	0.00287	CcSEcCtD
Nadolol—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00106	0.00286	CcSEcCtD
Nadolol—Mood swings—Methotrexate—psoriatic arthritis	0.00106	0.00285	CcSEcCtD
Nadolol—Hallucination—Betamethasone—psoriatic arthritis	0.00105	0.00284	CcSEcCtD
Nadolol—Hallucination—Dexamethasone—psoriatic arthritis	0.00105	0.00284	CcSEcCtD
Nadolol—Weight increased—Prednisone—psoriatic arthritis	0.00105	0.00283	CcSEcCtD
Nadolol—Vision blurred—Prednisolone—psoriatic arthritis	0.00104	0.00281	CcSEcCtD
Nadolol—Depression—Prednisone—psoriatic arthritis	0.00102	0.00276	CcSEcCtD
Nadolol—Visual impairment—Dexamethasone—psoriatic arthritis	0.00102	0.00275	CcSEcCtD
Nadolol—Visual impairment—Betamethasone—psoriatic arthritis	0.00102	0.00275	CcSEcCtD
Nadolol—Syncope—Prednisolone—psoriatic arthritis	0.000991	0.00267	CcSEcCtD
Nadolol—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000972	0.00262	CcSEcCtD
Nadolol—Hypertension—Prednisolone—psoriatic arthritis	0.000954	0.00257	CcSEcCtD
Nadolol—Bradycardia—Prednisone—psoriatic arthritis	0.000939	0.00253	CcSEcCtD
Nadolol—Alopecia—Betamethasone—psoriatic arthritis	0.000936	0.00252	CcSEcCtD
Nadolol—Alopecia—Dexamethasone—psoriatic arthritis	0.000936	0.00252	CcSEcCtD
Nadolol—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000924	0.00249	CcSEcCtD
Nadolol—Hallucination—Prednisone—psoriatic arthritis	0.000918	0.00247	CcSEcCtD
Nadolol—Syncope—Triamcinolone—psoriatic arthritis	0.000912	0.00246	CcSEcCtD
Nadolol—Syncope—Methylprednisolone—psoriatic arthritis	0.00091	0.00245	CcSEcCtD
Nadolol—Oedema—Prednisolone—psoriatic arthritis	0.000902	0.00243	CcSEcCtD
Nadolol—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000893	0.00241	CcSEcCtD
Nadolol—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000891	0.0024	CcSEcCtD
Nadolol—Shock—Prednisolone—psoriatic arthritis	0.000888	0.00239	CcSEcCtD
Nadolol—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000887	0.00239	CcSEcCtD
Nadolol—Cough—Triamcinolone—psoriatic arthritis	0.000887	0.00239	CcSEcCtD
Nadolol—Hypertension—Triamcinolone—psoriatic arthritis	0.000878	0.00236	CcSEcCtD
Nadolol—Hypertension—Methylprednisolone—psoriatic arthritis	0.000876	0.00236	CcSEcCtD
Nadolol—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000872	0.00235	CcSEcCtD
Nadolol—Depression—Methotrexate—psoriatic arthritis	0.000857	0.00231	CcSEcCtD
Nadolol—Dry mouth—Triamcinolone—psoriatic arthritis	0.000846	0.00228	CcSEcCtD
Nadolol—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000835	0.00225	CcSEcCtD
Nadolol—Oedema—Triamcinolone—psoriatic arthritis	0.00083	0.00224	CcSEcCtD
Nadolol—Syncope—Betamethasone—psoriatic arthritis	0.000827	0.00223	CcSEcCtD
Nadolol—Syncope—Dexamethasone—psoriatic arthritis	0.000827	0.00223	CcSEcCtD
Nadolol—Sweating—Methotrexate—psoriatic arthritis	0.000824	0.00222	CcSEcCtD
Nadolol—Shock—Triamcinolone—psoriatic arthritis	0.000816	0.0022	CcSEcCtD
Nadolol—Insomnia—Prednisolone—psoriatic arthritis	0.000816	0.0022	CcSEcCtD
Nadolol—Alopecia—Prednisone—psoriatic arthritis	0.000815	0.0022	CcSEcCtD
Nadolol—Shock—Methylprednisolone—psoriatic arthritis	0.000814	0.00219	CcSEcCtD
Nadolol—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000811	0.00218	CcSEcCtD
Nadolol—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000811	0.00218	CcSEcCtD
Nadolol—Paraesthesia—Prednisolone—psoriatic arthritis	0.00081	0.00218	CcSEcCtD
Nadolol—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000802	0.00216	CcSEcCtD
Nadolol—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000802	0.00216	CcSEcCtD
Nadolol—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.0008	0.00216	CcSEcCtD
Nadolol—Hypertension—Dexamethasone—psoriatic arthritis	0.000796	0.00215	CcSEcCtD
Nadolol—Hypertension—Betamethasone—psoriatic arthritis	0.000796	0.00215	CcSEcCtD
Nadolol—Hypotension—Methylprednisolone—psoriatic arthritis	0.000773	0.00208	CcSEcCtD
Nadolol—Pain—Prednisolone—psoriatic arthritis	0.000771	0.00208	CcSEcCtD
Nadolol—Vision blurred—Prednisone—psoriatic arthritis	0.000757	0.00204	CcSEcCtD
Nadolol—Oedema—Betamethasone—psoriatic arthritis	0.000753	0.00203	CcSEcCtD
Nadolol—Oedema—Dexamethasone—psoriatic arthritis	0.000753	0.00203	CcSEcCtD
Nadolol—Insomnia—Triamcinolone—psoriatic arthritis	0.00075	0.00202	CcSEcCtD
Nadolol—Insomnia—Methylprednisolone—psoriatic arthritis	0.000749	0.00202	CcSEcCtD
Nadolol—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000745	0.00201	CcSEcCtD
Nadolol—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000743	0.002	CcSEcCtD
Nadolol—Visual impairment—Methotrexate—psoriatic arthritis	0.000743	0.002	CcSEcCtD
Nadolol—Shock—Dexamethasone—psoriatic arthritis	0.000741	0.002	CcSEcCtD
Nadolol—Shock—Betamethasone—psoriatic arthritis	0.000741	0.002	CcSEcCtD
Nadolol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00074	0.00199	CcSEcCtD
Nadolol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00073	0.00197	CcSEcCtD
Nadolol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000729	0.00196	CcSEcCtD
Nadolol—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000728	0.00196	CcSEcCtD
Nadolol—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000728	0.00196	CcSEcCtD
Nadolol—Syncope—Prednisone—psoriatic arthritis	0.00072	0.00194	CcSEcCtD
Nadolol—Tinnitus—Methotrexate—psoriatic arthritis	0.000719	0.00194	CcSEcCtD
Nadolol—Anorexia—Betamethasone—psoriatic arthritis	0.000718	0.00193	CcSEcCtD
Nadolol—Anorexia—Dexamethasone—psoriatic arthritis	0.000718	0.00193	CcSEcCtD
Nadolol—Fatigue—Triamcinolone—psoriatic arthritis	0.000715	0.00193	CcSEcCtD
Nadolol—Fatigue—Methylprednisolone—psoriatic arthritis	0.000714	0.00192	CcSEcCtD
Nadolol—Pain—Triamcinolone—psoriatic arthritis	0.000709	0.00191	CcSEcCtD
Nadolol—Loss of consciousness—Prednisone—psoriatic arthritis	0.000706	0.0019	CcSEcCtD
Nadolol—Hypotension—Dexamethasone—psoriatic arthritis	0.000703	0.0019	CcSEcCtD
Nadolol—Hypotension—Betamethasone—psoriatic arthritis	0.000703	0.0019	CcSEcCtD
Nadolol—Hypertension—Prednisone—psoriatic arthritis	0.000693	0.00187	CcSEcCtD
Nadolol—Alopecia—Methotrexate—psoriatic arthritis	0.000681	0.00184	CcSEcCtD
Nadolol—Insomnia—Dexamethasone—psoriatic arthritis	0.000681	0.00183	CcSEcCtD
Nadolol—Insomnia—Betamethasone—psoriatic arthritis	0.000681	0.00183	CcSEcCtD
Nadolol—Paraesthesia—Betamethasone—psoriatic arthritis	0.000676	0.00182	CcSEcCtD
Nadolol—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000676	0.00182	CcSEcCtD
Nadolol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000663	0.00179	CcSEcCtD
Nadolol—Dyspepsia—Betamethasone—psoriatic arthritis	0.000663	0.00179	CcSEcCtD
Nadolol—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000656	0.00177	CcSEcCtD
Nadolol—Oedema—Prednisone—psoriatic arthritis	0.000656	0.00177	CcSEcCtD
Nadolol—Decreased appetite—Betamethasone—psoriatic arthritis	0.000654	0.00176	CcSEcCtD
Nadolol—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000654	0.00176	CcSEcCtD
Nadolol—Fatigue—Dexamethasone—psoriatic arthritis	0.000649	0.00175	CcSEcCtD
Nadolol—Fatigue—Betamethasone—psoriatic arthritis	0.000649	0.00175	CcSEcCtD
Nadolol—Shock—Prednisone—psoriatic arthritis	0.000645	0.00174	CcSEcCtD
Nadolol—Pain—Betamethasone—psoriatic arthritis	0.000644	0.00173	CcSEcCtD
Nadolol—Pain—Dexamethasone—psoriatic arthritis	0.000644	0.00173	CcSEcCtD
Nadolol—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000634	0.00171	CcSEcCtD
Nadolol—Vision blurred—Methotrexate—psoriatic arthritis	0.000633	0.0017	CcSEcCtD
Nadolol—Anorexia—Prednisone—psoriatic arthritis	0.000625	0.00168	CcSEcCtD
Nadolol—Dizziness—Prednisolone—psoriatic arthritis	0.000597	0.00161	CcSEcCtD
Nadolol—Asthenia—Triamcinolone—psoriatic arthritis	0.000595	0.0016	CcSEcCtD
Nadolol—Body temperature increased—Betamethasone—psoriatic arthritis	0.000595	0.0016	CcSEcCtD
Nadolol—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000595	0.0016	CcSEcCtD
Nadolol—Asthenia—Methylprednisolone—psoriatic arthritis	0.000594	0.0016	CcSEcCtD
Nadolol—Insomnia—Prednisone—psoriatic arthritis	0.000593	0.0016	CcSEcCtD
Nadolol—Paraesthesia—Prednisone—psoriatic arthritis	0.000589	0.00159	CcSEcCtD
Nadolol—Pruritus—Triamcinolone—psoriatic arthritis	0.000587	0.00158	CcSEcCtD
Nadolol—Cough—Methotrexate—psoriatic arthritis	0.000586	0.00158	CcSEcCtD
Nadolol—Pruritus—Methylprednisolone—psoriatic arthritis	0.000586	0.00158	CcSEcCtD
Nadolol—Dyspepsia—Prednisone—psoriatic arthritis	0.000577	0.00155	CcSEcCtD
Nadolol—Chest pain—Methotrexate—psoriatic arthritis	0.000571	0.00154	CcSEcCtD
Nadolol—Decreased appetite—Prednisone—psoriatic arthritis	0.00057	0.00154	CcSEcCtD
Nadolol—Rash—Prednisolone—psoriatic arthritis	0.000569	0.00153	CcSEcCtD
Nadolol—Dermatitis—Prednisolone—psoriatic arthritis	0.000568	0.00153	CcSEcCtD
Nadolol—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000566	0.00153	CcSEcCtD
Nadolol—Fatigue—Prednisone—psoriatic arthritis	0.000565	0.00152	CcSEcCtD
Nadolol—Constipation—Prednisone—psoriatic arthritis	0.000561	0.00151	CcSEcCtD
Nadolol—Dizziness—Triamcinolone—psoriatic arthritis	0.000549	0.00148	CcSEcCtD
Nadolol—Dizziness—Methylprednisolone—psoriatic arthritis	0.000547	0.00147	CcSEcCtD
Nadolol—Asthenia—Dexamethasone—psoriatic arthritis	0.00054	0.00146	CcSEcCtD
Nadolol—Asthenia—Betamethasone—psoriatic arthritis	0.00054	0.00146	CcSEcCtD
Nadolol—Nausea—Prednisolone—psoriatic arthritis	0.000536	0.00144	CcSEcCtD
Nadolol—Pruritus—Betamethasone—psoriatic arthritis	0.000533	0.00143	CcSEcCtD
Nadolol—Pruritus—Dexamethasone—psoriatic arthritis	0.000533	0.00143	CcSEcCtD
Nadolol—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00053	0.00143	CcSEcCtD
Nadolol—Vomiting—Triamcinolone—psoriatic arthritis	0.000527	0.00142	CcSEcCtD
Nadolol—Vomiting—Methylprednisolone—psoriatic arthritis	0.000526	0.00142	CcSEcCtD
Nadolol—Rash—Triamcinolone—psoriatic arthritis	0.000523	0.00141	CcSEcCtD
Nadolol—Dermatitis—Triamcinolone—psoriatic arthritis	0.000523	0.00141	CcSEcCtD
Nadolol—Anorexia—Methotrexate—psoriatic arthritis	0.000522	0.00141	CcSEcCtD
Nadolol—Rash—Methylprednisolone—psoriatic arthritis	0.000522	0.00141	CcSEcCtD
Nadolol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000521	0.0014	CcSEcCtD
Nadolol—Body temperature increased—Prednisone—psoriatic arthritis	0.000518	0.0014	CcSEcCtD
Nadolol—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000515	0.00139	CcSEcCtD
Nadolol—Diarrhoea—Betamethasone—psoriatic arthritis	0.000515	0.00139	CcSEcCtD
Nadolol—Hypotension—Methotrexate—psoriatic arthritis	0.000512	0.00138	CcSEcCtD
Nadolol—Dizziness—Dexamethasone—psoriatic arthritis	0.000498	0.00134	CcSEcCtD
Nadolol—Dizziness—Betamethasone—psoriatic arthritis	0.000498	0.00134	CcSEcCtD
Nadolol—Insomnia—Methotrexate—psoriatic arthritis	0.000496	0.00134	CcSEcCtD
Nadolol—Nausea—Triamcinolone—psoriatic arthritis	0.000493	0.00133	CcSEcCtD
Nadolol—Paraesthesia—Methotrexate—psoriatic arthritis	0.000492	0.00133	CcSEcCtD
Nadolol—Nausea—Methylprednisolone—psoriatic arthritis	0.000492	0.00132	CcSEcCtD
Nadolol—Dyspnoea—Methotrexate—psoriatic arthritis	0.000488	0.00132	CcSEcCtD
Nadolol—Dyspepsia—Methotrexate—psoriatic arthritis	0.000482	0.0013	CcSEcCtD
Nadolol—Vomiting—Betamethasone—psoriatic arthritis	0.000479	0.00129	CcSEcCtD
Nadolol—Vomiting—Dexamethasone—psoriatic arthritis	0.000479	0.00129	CcSEcCtD
Nadolol—Decreased appetite—Methotrexate—psoriatic arthritis	0.000476	0.00128	CcSEcCtD
Nadolol—Rash—Dexamethasone—psoriatic arthritis	0.000475	0.00128	CcSEcCtD
Nadolol—Rash—Betamethasone—psoriatic arthritis	0.000475	0.00128	CcSEcCtD
Nadolol—Dermatitis—Dexamethasone—psoriatic arthritis	0.000474	0.00128	CcSEcCtD
Nadolol—Dermatitis—Betamethasone—psoriatic arthritis	0.000474	0.00128	CcSEcCtD
Nadolol—Fatigue—Methotrexate—psoriatic arthritis	0.000472	0.00127	CcSEcCtD
Nadolol—Asthenia—Prednisone—psoriatic arthritis	0.00047	0.00127	CcSEcCtD
Nadolol—Pain—Methotrexate—psoriatic arthritis	0.000468	0.00126	CcSEcCtD
Nadolol—Pruritus—Prednisone—psoriatic arthritis	0.000464	0.00125	CcSEcCtD
Nadolol—Diarrhoea—Prednisone—psoriatic arthritis	0.000449	0.00121	CcSEcCtD
Nadolol—Nausea—Dexamethasone—psoriatic arthritis	0.000447	0.0012	CcSEcCtD
Nadolol—Nausea—Betamethasone—psoriatic arthritis	0.000447	0.0012	CcSEcCtD
Nadolol—Dizziness—Prednisone—psoriatic arthritis	0.000433	0.00117	CcSEcCtD
Nadolol—Body temperature increased—Methotrexate—psoriatic arthritis	0.000433	0.00117	CcSEcCtD
Nadolol—Vomiting—Prednisone—psoriatic arthritis	0.000417	0.00112	CcSEcCtD
Nadolol—Rash—Prednisone—psoriatic arthritis	0.000413	0.00111	CcSEcCtD
Nadolol—Dermatitis—Prednisone—psoriatic arthritis	0.000413	0.00111	CcSEcCtD
Nadolol—Asthenia—Methotrexate—psoriatic arthritis	0.000393	0.00106	CcSEcCtD
Nadolol—Nausea—Prednisone—psoriatic arthritis	0.000389	0.00105	CcSEcCtD
Nadolol—Pruritus—Methotrexate—psoriatic arthritis	0.000388	0.00104	CcSEcCtD
Nadolol—Diarrhoea—Methotrexate—psoriatic arthritis	0.000375	0.00101	CcSEcCtD
Nadolol—Dizziness—Methotrexate—psoriatic arthritis	0.000362	0.000976	CcSEcCtD
Nadolol—Vomiting—Methotrexate—psoriatic arthritis	0.000348	0.000939	CcSEcCtD
Nadolol—Rash—Methotrexate—psoriatic arthritis	0.000345	0.000931	CcSEcCtD
Nadolol—Dermatitis—Methotrexate—psoriatic arthritis	0.000345	0.00093	CcSEcCtD
Nadolol—Nausea—Methotrexate—psoriatic arthritis	0.000325	0.000877	CcSEcCtD
